Case-Control Study of the Risk Factors for Acquisition of Pseudomonas and Proteus Species during Tigecycline Therapy

Tigecycline is an important agent in clinical practice because of its broad-spectrum activity. However, it has no activity against Pseudomonas or Proteus species. We conducted a case-control study to analyze risk factors for the acquisition of Pseudomonas or Proteus spp. during tigecycline therapy....

詳細記述

保存先:
書誌詳細
出版年:Antimicrob Agents Chemother
主要な著者: Park, Ga Eun, Kang, Cheol-In, Wi, Yu Mi, Ko, Jae-Hoon, Lee, Woo Joo, Lee, Ji Yong, Cho, Sun Young, Ha, Young Eun, Chung, Doo Ryeon, Peck, Kyong Ran, Song, Jae-Hoon
フォーマット: Artigo
言語:Inglês
出版事項: American Society for Microbiology 2015
主題:
Clinical Therapeutics
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4538539/
https://ncbi.nlm.nih.gov/pubmed/26100705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.04865-14
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料